-
-
-
-
-
-
-
CVRx begins patient enrollment in major heart failure trial
-
-
-
-
-
-
-
Canaccord Genuity Reiterates Buy Rating on CVRx Inc (CVRX)
-
-
-
-
-
-
-
CVRx, Inc. (CVRX) Misses Q2 EPS by 5c ; Offers Guidance
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on CVRx Inc (CVRX)
-
-
-
-
-
-
-
CVRx Inc (CVRX) PT Raised to $22 at Craig-Hallum
-
-
-
-
-
-
-
Canaccord Genuity Reiterates Buy Rating on CVRx Inc (CVRX)
-
-
-
-
-
-
-
CVRx, Inc. (CVRX) Misses Q2 EPS by 10c, provides guidance
-
443,905 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

